A.P.H. Paris, Hopital Saint Louis ( Site 4107)

Paris 75010

0 studies enrolling now · 1 studies all time

What they study most

Melanoma

Studies at this site

• Substudy 02D: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02) — Completed